Ziconotide

Prialt 100 Microgramos/ML Solucion Para Perfusion

100 µg solución para perfusiónSpainMarketedAuthorised 16 Oct 2006

In other countries

The same active substances on other registers, the same brand first.

PrialtEuropean Union · Esteve Pharmaceuticals GmbHSame brand
PrialtCroatiaSame brand
PrialtItaly · Soluzione per infusione · Esteve Pharmaceuticals GmbHSame brand
Prialt 100 microgram/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · Riemser Pharma GmbHSame brand
Prialt 25 µg/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · Riemser Pharma GmbHSame brand
PrialtUnited States · 100MCG/1ML, 200MCG/2ML, 500MCG/20ML … · injectable · EsteveSame brand

Packs

Pack	Code	Status
PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 1 ml

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ziconotide

Prialt 100 Microgramos/ML Solucion Para Perfusion

100 µg solución para perfusiónSpainMarketedAuthorised 16 Oct 2006

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 1 ml

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ziconotide
Strength: 100 µg
Dosage form: solución para perfusión
Route: vía intratecal
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 16 Oct 2006
Registration: 04302001
Marketing authorisation holder: Esteve Pharmaceuticals Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario